Stock of interest

September 07, 2007

Martek Biosciences Corp.

Shares of the nutritional supplement maker fell $2.02, or 7 percent, to $25.79 yesterday on news that third-quarter revenue for the Columbia company was slightly below analyst estimates.

Baltimore Sun Articles
|
|
|
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.